The Honorable Gordon R. England, President
Chairman of the Board
V1 Analytical Solutions
Previous to his position at V1 Analytical Solutions, Gordon England was president of E6 Partners LLC, a firm specializing in defense, security, and mergers and acquisitions for domestic and international companies. He is the executive chairman of Totus Solutions, Inc., a firm specializing in lighting-based security solutions, and he is on the board of directors for various start-up technical companies.
Previously, Mr. England served as the 29th Deputy Secretary of Defense. He also served as the 72nd and 73rd Secretary of the Navy and as the first Deputy Secretary of the Department of Homeland Security.
Prior to joining the federal government, Mr. England served as president of the General Dynamics Fort Worth Division (later Lockheed Martin Aeronautics Company); as vice president of Engineering at General Dynamics Land Systems and later as president; and as corporate executive vice president of General Dynamics Information Systems and Technology Sector, Ground Combat Systems Sector, and the International Sector. His business career spanned over 40 years as an engineer specializing in aerospace avionics and senior executive positions.
A native of Baltimore, Mr. England graduated from the University of Maryland in 1961 with a bachelor's degree in electrical engineering. In 1975 he earned a master's degree in business administration from the M.J. Neeley School of Business at Texas Christian University. He is a distinguished alumnus of both universities. He is a member of business, engineering, and leadership honor societies. He serves on the board of trustees for the University of Maryland and is a chairman of the foundation board for the U.S. Naval Institute and chairman of the Heroes and Families Foundation.
Mr. England has served in a variety of civic, charitable and government organizations, including serving as a city councilman; vice chair, national board of Goodwill, International; the USO's Board of Governors; the Defense Science Board; the board of visitors at Texas Christian University; and many others. He has been recognized for numerous professional and service contributions by universities, professional and civic organizations, local government, and the Department of Defense.
Amelie G. Ramirez, Dr.P.H, M.P.H., Vice President
Director, Institute for Health Promotion Research
Dielmann Chair, Health Disparities and Community Outreach
The University of Texas Health Science Center at San Antonio
Amelie G. Ramirez, Dr.P.H., an internationally recognized researcher and spokesperson on Latino cancer health disparities, has made tremendous strides in research and innovative communication strategies to improve the health of Latinos in Texas and the nation.
Dr. Ramirez, currently the founding director of the Institute for Health Promotion Research (http://ihpr.uthscsa.edu) at The University of Texas Health Science Center at San Antonio, has led dozens of research programs focused on human and organizational communication to reduce disparities—differences in cancer rates and survival among Latinos compared to whites. Dr. Ramirez has launched two national research networks, one funded by the National Cancer Institute focused on Latino cancer (Redes En Acción, www.redesenaccion.org) and one funded by the Robert Wood Johnson Foundation focused on Latino child obesity (Salud America!, www.salud-america.org). These networks and her several other research projects have spawned unique health communication models and interventions that have contributed to reducing Latino cancer rates and increasing Latino screening, clinical trial recruitment and retention, smoking cessation and healthy lifestyles. She also has helped pioneer the use of bilingual, bicultural patient navigators and promotoras to erase Latinas’ lag times between an abnormal cancer screening and confirmatory diagnosis and treatment initiation, while also increasing Latina survivors’ access to support services.
Dr. Ramirez also has directly inspired other Latinos to launch research careers by training or mentoring more than 200 Latino students and fellows. She has made countless contributions to the scientific literature and serves on several journal editorial boards. Dr. Ramirez has received many awards for her work to reduce cancer disparities, including 2007 election to the Institute of Medicine. She is a member of: the Scientific Advisory Board, Susan G. Komen for the Cure; Scientific Advisory Board, Avon Foundation Breast Cancer Crusade; and Board of Directors, Lance Armstrong Foundation. She is associate director of cancer health disparities at the Cancer Therapy and Research Center (www.ctrc.net), an NCI-designated Cancer Center in San Antonio, and also is the former chairperson of the CDC’s Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Ramirez received M.P.H. and Dr.P.H. degrees from The University of Texas Health Science Center at Houston School of Public Health.
David W. Russell, Ph.D., Past President
Vice Provost and Dean of Basic Research
Eugene McDermott Distinguished Chair in Molecular Genetics
Professor, Biophysics and Molecular Genetics
The University of Texas Southwestern Medical Center
Dr. David W. Russell received a B.A. degree in biology from UT Austin in 1975 and a Ph.D. in chemistry from the University of North Carolina in 1980. He was a Damon Runyon Cancer Research Foundation postdoctoral fellow from 1980-1982 with Nobel Laureate Michael Smith (Chemistry, 1993) at the University of British Columbia. He joined the faculty at UT Southwestern in 1982, was promoted to professor in 1990, and received the McDermott Distinguished Chair of Molecular Genetics in 1992. Russell's research interests are in cholesterol metabolism, in particular the enzymatic pathways that dispose of cholesterol. His laboratory has isolated over a dozen genes that encode enzymes involved in cholesterol breakdown, and has identified the molecular bases of seven human genetic diseases characterized by abnormal lipid metabolism. Russell and Dr. Joseph Sambrook are the authors of the 3rd edition of the best-selling laboratory manual titled Molecular Cloning published by Cold Spring Harbor Laboratory Press. Russell is the recipient of a research career development award from the National Institutes of Health, the Katz Award from the American Heart Association, the Kilby Science Place award from Texas Instruments, the Oppenheimer Award from the U.S. Endocrine Society, the Windaus Prize from the Falck Foundation of Germany, the Avanti Award in Lipids from the American Society of Biochemistry and Molecular Biology, and the Barbara H. Bowman Distinguished Geneticist Award from the Texas Genetics Society. He was elected to the U.S. National Academy of Sciences in 2006 and the American Academy of Arts & Sciences in 2011.
Russell teaches introductory and advanced courses in biochemistry and molecular biology to medical and graduate students, and is a member of numerous administrative committees at the medical school. He has served on the editorial boards of Biochemistry, Annual Reviews of Biochemistry, Journal of Biological Chemistry, Trends in Biochemical Sciences and Molecular Endocrinology, and now serves on the editorial boards of Cell Metabolism, the Journal of Lipid Research and the Proceedings of the National Academy of Sciences, U.S.A. He reviews research grant applications and programs for the US National Institutes of Health and the Howard Hughes Medical Institute, and is a consultant to law firms, the pharmaceutical industry, and biotechnology companies.
In December of 2010, Russell joined the UT Southwestern administration as Vice Provost and Dean of Basic Research. His responsibilities include strategic planning and development of research initiatives across campus, research faculty recruitment to departments and centers, and oversight of the basic science departments, graduate education, the Animal Resource Center, and core laboratory facilities.
Kenneth E. Arnold, P.E., Treasurer
Senior Technical Advisor
In 1980, Ken Arnold founded Paragon Engineering Services, a 600 person company providing engineering services to the upstream oil and gas, and pipeline industries. Paragon was sold in 2005 to AMEC, a UK based global project management and services company. Arnold is currently a Senior Technical Advisor for WorleyParsons and an independent consultant to the oil and gas industry. Prior to forming Paragon, he had 16 years experience with Shell as an engineer, research department manager and engineering manager. In the 1980s, Arnold developed and published in a series of articles a rational basis for sizing gas-liquid separators, oil-water separators, oil treating systems and produced water treating systems based on droplet settling theory. This formed the basis of two textbooks he co-authored on the design and project management of oilfield production facilities which have gone through multiple printings and two editions and are still being used in petroleum engineering schools around the world.
Since the late 1980s, most of Arnold’s publications have been in the area of offshore safety and project management, and he has won awards from API and SPE for his work in promoting offshore safety. He was the Texas Society of Professional Engineers, Houston Engineer of the Year in 2003 and won the Society of Petroleum Engineers Public Service Award in 2006, the DeGoyler Award in 2007 and Honorary Membership in 2008. His two greatest achievements were realized when Paragon was named one of the ten best places to work in its size range by the Houston Business Journal in 2002 and when AMEC Paragon received the Texas Association of Partners in Education Gold Award in 2006 for pioneering work they did in setting up a partnership with SBISD for mentoring, tutoring, Texas Scholars and teacher for a day programs.
Brendan Lee, M.D., Ph.D., Treasurer-Elect
Robert and Janice McNair Endowed Chair in Molecular and Human Genetics
Professor and Chairman of the Department of Molecular and Human Genetics
Baylor College of Medicine
Dr. Lee is the Robert and Janice McNair Endowed Chair in Molecular and Human Genetics, Professor and Chairman of the Department of Molecular and Human Genetics at Baylor College of Medicine. Dr. Lee co-directs the joint MD Anderson Cancer Center, University of Texas, and Baylor College of Medicine Rolanette and Berdon Lawrence Bone Disease Program of Texas, and the Baylor College of Medicine Center for Skeletal Medicine and Biology. He is Founder and Director of the Skeletal Dysplasia Clinic at Texas Children’s Hospital, and of the Medical Student Research Track at Baylor. As a pediatrician and geneticist, Dr. Lee studies structural birth defects and inborn errors of metabolism. Dr. Lee identified the first genetic causes of human skeletal dysplasias that affect the growth and strength of the skeleton. He has discovered new causes of brittle bone disease in children. In so doing, he has identified key regulators of bone mass and quality which has led to new approaches for diagnosing and treating these disorders. In the area of metabolic disease, he is has developed new treatments for maple syrup urine disease and urea cycle disorders that are identified at birth by comprehensive newborn screening. Dr. Lee has received local and national recognition including election to the National Academy of Medicine (previously the Institute of Medicine), as Fellow of the American Association for the Advancement of Science (AAAS), the Texas Academy of Medicine, Engineering, Science, and Technology (TAMEST), the Association of American Physicians (AAP), the American Society for Clinical Investigation (ASCI), and the Society of Pediatric Research (SPR). He has also been awarded the American Society of Human Genetic Curt Stern Award for Outstanding Scientific Achievement, the TAMEST Peter and Edith O’Donnell Award in Medicine, the Society for Pediatrics Research E. Meade Johnson Award for Pediatrics Research, the Michael E. DeBakey Excellence in Research Award, the American Philosophical Society’s (APS) Judson Darland Prize for Patient-Oriented Clinical Investigation, and Best Doctors in America.
Dr. Lee’s research mission is to elucidate developmental and biochemical pathways that regulate organogenesis and postnatal homeostasis, and to translate these discoveries into new diagnostic and therapeutic approaches including FDA-approved treatments. By studying Mendelian genetic diseases, he has elucidated physiological mechanisms that can also contribute to common, complex diseases (osteoarthritis, osteoporosis, and hypertension) as well as cancer (osteosarcoma). His program spans from basic mechanistic studies to clinical longitudinal and interventional trials in two areas: Structural birth defects with focus on the skeletal dysplasias and inborn errors of metabolism (IEM) with focus on the urea cycle disorders (UCD). By identifying targets from these rare diseases, he has developed therapies that may be translated in humans in proof of principle studies and eventually for future commercialization and wider application.
Dr. Lee was previously an Investigator of the Howard Hughes Medical Institute prior to becoming Chairman of the Department of Molecular and Human Genetics. The Department is the leading genetics program integrating basic, translational, clinical, and diagnostic laboratory activities. It is composed of over 70 primary tenured and tenure-track faculty and over 180 total faculty encompassing research, clinical, laboratory diagnostic, and genetic counseling. It ranks #1 in total NIH funding and number of NIH grants.
Danny D. Reible, Ph.D., Secretary
Donovan Maddox Distinguished Engineering Chair
Environmental and Water Resources, Civil and Environmental Engineering
Texas Tech University
Dr. Reible is the Donovan Maddox Distinguished Engineering Chair at Texas Tech University. Previously he was the Bettie Margaret Smith Chair of Environmental Health Engineering in the Department of Civil, Architectural and Environmental Engineering and the director of the Center for Research in Water Resources at The University of Texas in Austin. He holds a Ph.D. in chemical engineering from the California Institute of Technology. He is a Board Certified Environmental Engineer, a Professional Engineer (LA), and in 2005 was elected to the National Academy of Engineering for the “development of widely used approaches for the management of contaminated sediments.” In 2012 he helped found and currently chairs the International Society of Water Solutions, a society focused on industrial water management. He also chaired the program committee for TAMEST’s 2012 Texas Water Summit on the assessment and management of Texas water resources.
Dr. Reible’s research is focused on the fate, transport, and management of contaminants in the environment and the sustainable management of water resources. Current interests include the assessment of bioavailability of mercury and hydrophobic organics in sediments and their in-situ remediation. He has also evaluated the impacts of coastal flooding, e.g. during hurricanes, on contaminant mobility and availability. His water resources work has included water management for hydraulic fracturing for shale gas and oil and the efficient allocation of water resources, particularly in the face of drought.
New Board Members
Bonnie J. Dunbar, Ph.D.
Professor, Department of Aerospace
Director, TEES Institute
TEES Institute of Engineering Education & Innovation
Texas A&M University
Bonnie Dunbar is a retired NASA astronaut, engineer and educator, currently with Texas A&M Engineering as a Texas A&M Engineering Experiment Station (TEES) Distinguished Research Professor in the Department of Aerospace Engineering. She also has a joint appointment as the Director of the TEES Institute for Engineering Education and Innovation (IEEI).
Dunbar, who is a member of the prestigious National Academy of Engineering, came to Texas A&M from the University of Houston where she was an M.D. Anderson Professor of Mechanical Engineering. There she provided leadership in the development of a new integrated university science, technology, engineering and mathematics (STEM) center and was Director of the Science and Engineering Fair of Houston. She also directed the SICSA Space Architecture and Aerospace graduate programs. She has devoted her life to furthering engineering, engineering education, and the pursuit of human space exploration.
Dunbar worked for The Rockwell International Space Division Company building Space Shuttle Columbia and worked for 27 years at NASA, first as a flight controller; then as a mission specialist astronaut, where she flew five space shuttle flights, logging more than 50 days in space; and then served for seven years as a member of the Senior Executive Service (SES). Her executive service included assistant NASA JSC director for university research; deputy director for Flight Crew Operations; Associate Director for ISS Mission Operations development, and as NASA headquarters deputy associate administrator for the Office of Life and Microgravity Sciences and Applications (OLMSA).
After retiring from NASA, Dunbar became president and CEO of The Museum of Flight in Seattle, where she established a new Space Gallery and expanded its K-12 STEM educational offerings. She has also consulted in aerospace and STEM education as the president of Dunbar International LLC, and is an internationally known public speaker.
Dunbar holds bachelor and master degrees in ceramic engineering from the University of Washington and a Ph.D. in mechanical/biomedical engineering from the University of Houston. She is a Fellow of the American Ceramic Society, the American Institute of Aeronautics and Astronautics, and the Royal Aeronautical Society. She has been awarded the NASA Space Flight Medal five times, the NASA Exceptional Leadership Medal and the NASA Distinguished Service Medal. Dunbar was inducted into the Royal Society of Edinburgh, and in 2002 was elected to the National Academy of Engineering. In 2012, she was elected into the Association of Space Explorers' International Executive Committee, and in 2013 she was inducted into the U.S. Astronaut Hall of Fame.
Peter J. Hotez, M.D., Ph.D.
President of the Sabin Vaccine Institute
Dean of the National School of Tropical Medicine
Professor of Pediatrics and Molecular Virology & Microbiology
Texas Children’s Hospital Endowed Chair of Tropical Pediatrics
Baylor College of Medicine
Dr. Hotez is an internationally-recognized physician-scientist in neglected tropical diseases and vaccine development. He leads the only product development partnership for developing new vaccines for hookworm infection, schistosomiasis, and Chagas disease, and SARS/MERS, diseases affecting hundreds of millions of children and adults worldwide. In 2006 at the Clinton Global Initiative he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people.
He obtained his undergraduate degree in molecular biophysics from Yale University in 1980 (phi beta kappa), followed by a Ph.D. degree in biochemistry from Rockefeller University in 1986, and an M.D. from Weil Cornell Medical College in 1987.
Dr. Hotez has authored more than 400 original papers and is the author of the acclaimed Forgotten People, Forgotten Diseases (ASM Press) and the recently released Blue Marble Health: An Innovative Plan to Fight Diseases of the Poor amid Wealth (Johns Hopkins University Press). Dr. Hotez served previously as President of the American Society of Tropical Medicine and Hygiene and he is founding Editor-in-Chief of PLoS Neglected Tropical Diseases. He is an elected member of the National Academy of Medicine (formerly the Institute of Medicine – IOM), and in 2011 he was awarded the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health by the Pan American Health Organization of the WHO. In 2014 the White House and U.S. State Department selected Dr. Hotez as its United States Science Envoy.
David J. Mangelsdorf, Ph.D.
Professor and Chair of the Department of Pharmacology
Investigator, Howard Hughes Medical Institute
Alfred G. Gilman Distinguished Chair in Pharmacology
Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology
The University of Texas Southwestern Medical Center
David J. Mangelsdorf received his B.S. in Biology and Chemistry from Northern Arizona University in Flagstaff (1981) and his Ph.D. in Biochemistry from the University of Arizona in Tucson (1987). He did his postdoctoral studies at The Salk Institute for Biological Studies. Since 1993, he has been at The University of Texas Southwestern Medical Center (UT Southwestern), where he currently is Professor and Chair of the Department of Pharmacology, and an Investigator of the Howard Hughes Medical Institute. He holds the Alfred G. Gilman Distinguished Chair in Pharmacology and the Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology, in Honor of Harold B. Crasilneck, Ph.D. He has been a member of the National Academy of Sciences and The Academy of Medicine, Engineering and Science of Texas since 2008.
Dr. Mangelsdorf’s research interests are focused on the role of nuclear receptors in governing nutrient metabolism. The discovery of ligands and functions for several of these receptors has led to the identification of new therapeutic targets for atherosclerosis, cholestasis, and type 2 diabetes. Since 2003, Mangelsdorf has been working jointly with Dr. Steven Kliewer at UT Southwestern. Their work has revealed the existence of two nuclear receptor-initiated endocrine signaling pathways that govern feeding and fasting responses and are mediated by the fibroblast growth factors FGF19 and FGF21. Recently, their lab discovered an orthologous nuclear receptor pathway that is conserved in parasitic nematodes, and they have shown that targeting this pathway may represent a novel therapeutic strategy for fighting parasitism.
Antonios G. Mikos, Ph.D.
Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering
Director, J.W. Cox Laboratory for Biomedical Engineering and the Director of the Center for Excellence in Tissue Engineering
Antonios G. Mikos is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He is the Director of the J.W. Cox Laboratory for Biomedical Engineering and the Director of the Center for Excellence in Tissue Engineering at Rice University. His research focuses on the synthesis, processing, and evaluation of new biomaterials for use as scaffolds for tissue engineering, as carriers for controlled drug delivery, and as non-viral vectors for gene therapy. His work has led to the development of novel orthopaedic, dental, cardiovascular, neurologic, and ophthalmologic biomaterials. He is the author of over 550 publications and 28 patents. He is organizer of the continuing education course Advances in Tissue Engineering offered annually at Rice University since 1993.
Dr. Mikos is a Member of the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, The Academy of Medicine, Engineering and Science of Texas (TAMEST), and the Academy of Athens. He has been recognized by various awards including the Lifetime Achievement Award of the Tissue Engineering and Regenerative Medicine International Society-Americas, the Founders Award of the Society For Biomaterials, and TAMEST's Edith and Peter O’Donnell Award in Engineering. He is a founding editor and editor-in-chief of the journal Tissue Engineering, and a Past-President of the Tissue Engineering and Regenerative Medicine International Society-Americas and the Society For Biomaterials.